AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20801180 — intervention group
Group type: COMPARATOR
Intervention: Weight loss intervention for obese and overweight persons without anhedonia
Number of subjects: 82
Study 20801180 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of binge eating using the Binge Eating Scale (BES)
Number of subjects: 82
Study 20801180 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of eating behavior using the Three Factor Eating Questionnaire (TFEQ‐18)
Number of subjects: 82
Study 18236347 — intervention group
Group type: EXPERIMENTAL
Intervention: Handsearching of 85 health care journals for RCTs and CCTs
Number of subjects: 18491
Study 18236347 — intervention group
Group type: EXPERIMENTAL
Intervention: Handsearching of journals not indexed in Medline
Number of subjects: 18491
Study 16628640 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alpha‐2b for 8 weeks (group A; n=34)
Number of subjects: 161
Study 16628640 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alpha‐2b for 12 weeks (group B; n=34)
Number of subjects: 161
Study 16628640 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alpha‐2b for 24 weeks (group C; n=34)
Number of subjects: 161
Study 16628640 — intervention group
Group type: EXPERIMENTAL
Intervention: 8- and 12-week regimens
Number of subjects: 161
Study 16628640 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonrandomized, n=30)
Number of subjects: 161
Study 15006014 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release oxycodone (CRO) 20 mg
Number of subjects: 40
Study 15006014 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 40
Study 11491366 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH/human menopausal gonadotropin combination
Number of subjects: 0
Study 11491366 — intervention group
Group type: EXPERIMENTAL
Intervention: FSH exclusively
Number of subjects: 0
Study 9663214 — intervention group
Group type: EXPERIMENTAL
Intervention: Black patients
Number of subjects: 591
Study 9663214 — intervention group
Group type: COMPARATOR
Intervention: White patients
Number of subjects: 591
Study 9663214 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 591
Study 8148352 — intervention group
Group type: COMPARATOR
Intervention: Baseline diet (36% kcal as fat: 15% saturated, 15% monounsaturated, and 6% polyunsaturated fat; 180 mg cholesterol.1000 kcal‐1)
Number of subjects: 15
Study 8148352 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil diet
Number of subjects: 15
Study 8148352 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil diet
Number of subjects: 15
Study 8148352 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola oil diet
Number of subjects: 15
Study 8148352 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-oil diets (olive, corn, canola)
Number of subjects: 15
Study 3276228 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 19
Study 3276228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 31715584 — intervention group
Group type: EXPERIMENTAL
Intervention: Postexercise glucose-fructose coingestion (1.5 g·kg‐1·hr‐1 carbohydrate)
Number of subjects: 16
Study 31715584 — intervention group
Group type: EXPERIMENTAL
Intervention: Postexercise glucose-fructose coingestion (1.2 g·kg‐1·hr‐1 carbohydrate)
Number of subjects: 16
Study 31715584 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric glucose alone
Number of subjects: 16
Study 30531253 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with everolimus-eluting stents
Number of subjects: 1905
Study 30531253 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1905
Study 30531253 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1905
Study 30531253 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PCI and CABG
Number of subjects: 1905
Study 28855239 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop control (CLC) system
Number of subjects: 32
Study 26274967 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosenberg Self-Esteem Scale (SES)
Number of subjects: 36
Study 26274967 — intervention group
Group type: EXPERIMENTAL
Intervention: Female Sexual Function Index (FSFI)
Number of subjects: 36
Study 26274967 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior Trunk Symmetry Index (POTSI)
Number of subjects: 36
Study 23577069 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 40,000 IU intravenously
Number of subjects: 11
Study 23577069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 21561959 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (up to 200 mg/day for 8 weeks)
Number of subjects: 121
Study 21561959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 21561959 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 121
Study 21561959 — intervention group
Group type: COMPARATOR
Intervention: Modafinil and Placebo
Number of subjects: 121
Study 19935032 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator tape
Number of subjects: 199
Study 19935032 — intervention group
Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 199
Study 19935032 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 199
Study 16513451 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (80 mg)
Number of subjects: 25
Study 16513451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 16513451 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 25
Study 12595969 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid+ (10 mg/day, n=17)
Number of subjects: 27
Study 12595969 — intervention group
Group type: COMPARATOR
Intervention: Steroid- (n=10)
Number of subjects: 27
Study 10989265 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (1.7 mg/kg)
Number of subjects: 16
Study 10989265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9069450 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil (300 to 900 mg/day)
Number of subjects: 57
Study 9069450 — intervention group
Group type: COMPARATOR
Intervention: Dietary counseling
Number of subjects: 57
Study 8439016 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil
Number of subjects: 30
Study 8439016 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine
Number of subjects: 30
Study 3535000 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar gum
Number of subjects: 0
Study 3535000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31981307 — intervention group
Group type: EXPERIMENTAL
Intervention: Angle kappa-customized placement of SBL-3 MIOL
Number of subjects: 40
Study 31981307 — intervention group
Group type: COMPARATOR
Intervention: Horizontal IOL placement (control group)
Number of subjects: 40
Study 29846686 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium alginate sheet (CA) group
Number of subjects: 200
Study 29846686 — intervention group
Group type: COMPARATOR
Intervention: No drug-eluting sheet (control) group
Number of subjects: 200
Study 28719405 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric I therapeutic activities (348-939 MBq)
Number of subjects: 86
Study 26180512 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 80
Study 26180512 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 80
Study 26180512 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 24862977 — intervention group
Group type: EXPERIMENTAL
Intervention: PM(2.5) increase (7.0 µg/m³)
Number of subjects: 49
Study 24862977 — intervention group
Group type: EXPERIMENTAL
Intervention: CO increase (161.7 parts per billion)
Number of subjects: 49
Study 24862977 — intervention group
Group type: EXPERIMENTAL
Intervention: O₃ increase
Number of subjects: 49
Study 24862977 — intervention group
Group type: EXPERIMENTAL
Intervention: SO₂ increase
Number of subjects: 49
Study 22052264 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNTA product 1
Number of subjects: 20
Study 22052264 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNTA product 2
Number of subjects: 20
Study 22052264 — intervention group
Group type: COMPARATOR
Intervention: Frontalis Rating Scale (FRS)
Number of subjects: 20
Study 22052264 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontalis Activity Measurement Standard (FMS)
Number of subjects: 20
Study 19423029 — intervention group
Group type: EXPERIMENTAL
Intervention: Debridement plus topical antifungal nail lacquer
Number of subjects: 55
Study 19423029 — intervention group
Group type: COMPARATOR
Intervention: Debridement alone
Number of subjects: 55
Study 17374661 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg treatment (640 mg/d additional cholesterol and 600 µg/d additional lutein + zeaxanthin)
Number of subjects: 22
Study 17374661 — intervention group
Group type: COMPARATOR
Intervention: Baseline treatment (no additional cholesterol or lutein + zeaxanthin)
Number of subjects: 22
Study 15546428 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle education intervention
Number of subjects: 73
Study 11476766 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (40 mg/d, p.o.)
Number of subjects: 40
Study 11476766 — intervention group
Group type: COMPARATOR
Intervention: Control group (no testosterone supplementation)
Number of subjects: 40
Study 9916606 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil 500 mg BID
Number of subjects: 278
Study 9916606 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate 500 mg/125 mg TID
Number of subjects: 278
Study 7803354 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative norfloxacin eyedrops
Number of subjects: 80
Study 7803354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 3054453 — intervention group
Group type: COMPARATOR
Intervention: Adriamycin (AD) alone
Number of subjects: 122
Study 3054453 — intervention group
Group type: EXPERIMENTAL
Intervention: VP-16 plus lower dose adriamycin (VAD)
Number of subjects: 122
Study 31733813 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured six-session psychological treatment
Number of subjects: 384
Study 31733813 — intervention group
Group type: COMPARATOR
Intervention: Routine antenatal health care and three monthly phone calls
Number of subjects: 384
Study 29874649 — intervention group
Group type: EXPERIMENTAL
Intervention: EPS+ bacterial pellets
Number of subjects: 2
Study 29874649 — intervention group
Group type: COMPARATOR
Intervention: EPS- bacterial pellets
Number of subjects: 2
Study 28710902 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session cognitive behavioural therapy intervention including a risk communication module
Number of subjects: 200
Study 28710902 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 200
Study 25789661 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarucizumab (doses between 20 mg and 8 g as a 1-hour intravenous infusion, or 1, 2 or 4 g as a 5-minute infusion)
Number of subjects: 110
Study 25789661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 24314123 — intervention group
Group type: EXPERIMENTAL
Intervention: ELLIPTA DPI
Number of subjects: 75
Study 21411203 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine screening for CAD
Number of subjects: 1665
Study 21411203 — intervention group
Group type: COMPARATOR
Intervention: No screening for CAD
Number of subjects: 1665
Study 19470877 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy with Aml/Val/HCTZ 10/320/25 mg
Number of subjects: 4285
Study 19470877 — intervention group
Group type: COMPARATOR
Intervention: Dual therapies (Val/HCTZ 320/25 mg, Aml/Val 10/320 mg, Aml/HCTZ 10/25 mg)
Number of subjects: 4285
Study 17407632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive multi-injection protocol (two or four times daily regular/NPH insulin injections)
Number of subjects: 102
Study 17407632 — intervention group
Group type: EXPERIMENTAL
Intervention: Four times daily insulin injections
Number of subjects: 102
Study 17407632 — intervention group
Group type: COMPARATOR
Intervention: Implementation of intensive protocol
Number of subjects: 102
Study 15379417 — intervention group
Group type: COMPARATOR
Intervention: Adiponectin serum concentrations in obese children
Number of subjects: 0
Study 15379417 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin serum concentrations in non-obese children
Number of subjects: 0
Study 15379417 — intervention group
Group type: COMPARATOR
Intervention: Serum leptin concentrations in obese children
Number of subjects: 0
Study 15379417 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum leptin concentrations in non-obese children
Number of subjects: 0
Study 15379417 — intervention group
Group type: COMPARATOR
Intervention: Leptin/adiponectin (L/A) ratio in obese children
Number of subjects: 0
Study 15379417 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin/adiponectin (L/A) ratio in non-obese children
Number of subjects: 0
Study 15204127 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-choice task where participants selected possibilities indicating truth or falsity of compound verbal propositions.
Number of subjects: 0
Study 15204127 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued recall task of verbal propositions.
Number of subjects: 0
Study 15204127 — intervention group
Group type: EXPERIMENTAL
Intervention: Old/new recognition paradigm for logical connectives.
Number of subjects: 0
Study 10407930 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexercise static stretching (4 x 20 s for hamstring muscle group)
Number of subjects: 10
Study 10407930 — intervention group
Group type: COMPARATOR
Intervention: Nonstretched legs (control)
Number of subjects: 10
Study 7555478 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 60
Study 7555478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 2147536 — intervention group
Group type: EXPERIMENTAL
Intervention: Thallium-201 (Tl-201) SPECT
Number of subjects: 24
Study 2147536 — intervention group
Group type: COMPARATOR
Intervention: Technetium-99m hexakis 2-methoxyisobutyl isonitrile (Tc-99m MIBI) SPECT
Number of subjects: 24
Study 2147536 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Tl-201 SPECT
Number of subjects: 24
Study 2147536 — intervention group
Group type: COMPARATOR
Intervention: Exercise Tc-99m MIBI SPECT
Number of subjects: 24
Study 7377911 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline once daily
Number of subjects: 124
Study 7377911 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline three times daily
Number of subjects: 124
Study 29190236 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab
Number of subjects: 19
Study 29190236 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 19
Study 28985105 — intervention group
Group type: EXPERIMENTAL
Intervention: Jones Jig
Number of subjects: 45
Study 28985105 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal Jet
Number of subjects: 45
Study 28985105 — intervention group
Group type: COMPARATOR
Intervention: Control (Untreated)
Number of subjects: 45
Study 28985105 — intervention group
Group type: EXPERIMENTAL
Intervention: Jones Jig and Distal Jet (Experimental Groups)
Number of subjects: 45
Study 27621158 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to take daily probiotics (from October 2013 to March 2014)
Number of subjects: 1302
Study 27621158 — intervention group
Group type: COMPARATOR
Intervention: Standard winter advice leaflet (control group)
Number of subjects: 1302
Study 27621158 — intervention group
Group type: EXPERIMENTAL
Intervention: Accessing probiotics (among those who did)
Number of subjects: 1302
Study 27621158 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to take daily probiotics
Number of subjects: 1302
Study 24793365 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis dependence
Number of subjects: 20
Study 24793365 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis dependence (non-abstinent)
Number of subjects: 20
Study 24793365 — intervention group
Group type: COMPARATOR
Intervention: Healthy comparison (HC)
Number of subjects: 20
Study 21926277 — intervention group
Group type: EXPERIMENTAL
Intervention: telephone coaching intervention
Number of subjects: 142
Study 21926277 — intervention group
Group type: COMPARATOR
Intervention: control
Number of subjects: 142
Study 20077490 — intervention group
Group type: EXPERIMENTAL
Intervention: Autofluorescence and diffuse reflectance spectroscopy and spectral imaging
Number of subjects: 28
Study 20077490 — intervention group
Group type: EXPERIMENTAL
Intervention: Separate algorithm for neo‐adjuvant chemotherapy‐treated tissues
Number of subjects: 28
Study 20077490 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence and reflectance-based spectral images
Number of subjects: 28
Study 17690392 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 181
Study 17690392 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine-sulfalene-pyrimethamine (ASP)
Number of subjects: 181
Study 15637546 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 1351
Study 12010236 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavernosal injection therapy without sexological counselling (‐SC)
Number of subjects: 70
Study 12010236 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavernosal injection therapy with sexological counselling (+SC)
Number of subjects: 70
Study 12010236 — intervention group
Group type: COMPARATOR
Intervention: Control group (‐SC)
Number of subjects: 70
Study 12010236 — intervention group
Group type: COMPARATOR
Intervention: Control group (+SC)
Number of subjects: 70
Study 11011620 — intervention group
Group type: EXPERIMENTAL
Intervention: Viaclin dynamic mattress overlay
Number of subjects: 87
Study 11011620 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 87
Study 7787382 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized epileptiform activity in the EEG (n = 12)
Number of subjects: 100
Study 7787382 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal changes in the EEG (n = 18)
Number of subjects: 100
Study 31736162 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate concentrations in boreal lakes
Number of subjects: 0
Study 31736162 — intervention group
Group type: EXPERIMENTAL
Intervention: N2 O emissions from lakes
Number of subjects: 0
Study 31736162 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual N2 O emission estimates for Finnish lakes
Number of subjects: 0
Study 31736162 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual N2 O emission estimates for boreal lakes
Number of subjects: 0
Study 31736162 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversaturation of N2 O in surface water samples
Number of subjects: 0
Study 31736162 — intervention group
Group type: EXPERIMENTAL
Intervention: Global warming potential of N2 O from lakes
Number of subjects: 0
Study 29683483 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective surgery
Number of subjects: 107
Study 29683483 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 107
Study 26710869 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux hemodialysis (HFHD)
Number of subjects: 60
Study 26710869 — intervention group
Group type: COMPARATOR
Intervention: Low-flux hemodialysis (LFHD)
Number of subjects: 60
Study 24219770 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer- and health-professional-led self-management education using the Stanford Program
Number of subjects: 43
Study 21434485 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanolic extract of Ruta Chalepensis L. (250 microg/ml)
Number of subjects: 56
Study 21434485 — intervention group
Group type: EXPERIMENTAL
Intervention: Rutin (1 mM)
Number of subjects: 56
Study 21434485 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 56
Study 21434485 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer patients (both early and advanced stages)
Number of subjects: 56
Study 21434485 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer patients (advanced stage)
Number of subjects: 56
Study 21434485 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer patients (early stage)
Number of subjects: 56
Study 18555220 — intervention group
Group type: EXPERIMENTAL
Intervention: Isopropanolic extract of Cimicifuga racemosa
Number of subjects: 0
Study 18555220 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum from treated women
Number of subjects: 0
Study 16546587 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 15
Study 16546587 — intervention group
Group type: COMPARATOR
Intervention: MAL-PDT
Number of subjects: 15
Study 15273672 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education and a physician alerting system (intervention group)
Number of subjects: 51
Study 15273672 — intervention group
Group type: COMPARATOR
Intervention: Usual care for the fracture (control group)
Number of subjects: 51
Study 11203735 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% capsaicin cream applied 4 times daily for 4 weeks
Number of subjects: 30
Study 11203735 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle cream) applied 4 times daily for 4 weeks
Number of subjects: 30
Study 9349063 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercuff technique
Number of subjects: 0
Study 9349063 — intervention group
Group type: COMPARATOR
Intervention: Normal cuff technique
Number of subjects: 0
Study 8455153 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold-palladium alloy
Number of subjects: 630
Study 8455153 — intervention group
Group type: COMPARATOR
Intervention: Alternative alloys
Number of subjects: 630
Study 3534850 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 14
Study 3534850 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 14
Study 30380365 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (laparoscopy or robot-assisted surgery)
Number of subjects: 631
Study 30380365 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 631